Are you and your patients ready for the fight against the new epidemics: obesity and type 2 diabetes?

Loading Map....

Date/Time
Date(s) - Jun 21, 2015
10:00 am - 12:00 pm

Location
Langara College

Categories


First lecture第一讲

Time: 10 am to 12 pm (2 CEU)

Title: Are you and your patients ready for the fight against the new epidemics: obesity and type 2

diabetes?

Language: English with Chinese PPT

Speaker: Dr. Zhitong Zhu MD, PhD (China)

Speaker Bio./Resume:

Dr. Zhitong (Isabel) Zhu is working at the St. Paul’s Hospital, Vancouver, Canada. Based on her clinical

experience, she has brought fruits into the fields of clinical trials, data management, and preclinical

research. In addition to a MHSc degree in Clinical Epidemiology from the University of British

Columbia, Dr. Zhu holds a MD, Master in Pharmacology, and a PhD degree in Pathogen Biology from

the Tianjin Medical University, China. She started to practice Internal Medicine and assisted clinical trials

in 1994. Over the years, she had been actively involved in new drug screening and action mechanism

studies, organized post-marketing surveillance and regulatory affairs projects, supervised marketing

authorization and registration. Recently, her research fields are more focused on designing, setting up,

managing, and analyzing longitudinal and clinical trial databases.

Introduction:

The past decade has witnessed a dramatic increase in both obesity and type 2 diabetes. The prevalence of

the two epidemics has posed a threat to the global public health systems. Once ‘a disease of affluence’,

type 2 diabetes has become increasingly prevalent among the poor. Once known as an adult-onset disease,

type 2 diabetes has changed to a disease of children and young adults. There are 285 million diabetes

patients worldwide, among which 2 million are Canadians. Overweight, especially obesity, is a primary

risk factor for type 2 diabetes. Strikingly, around a quarter of Canadians aged 15 years old or older

reported themselves as overweight, including obesity. In the face of the new epidemics, are you well

equipped to help your patients prevent or manage obesity and type 2 diabetes?

In this lecture, Dr. Zhu will share her unique perspectives and insights from her clinical practice and

research experience. You will get updated on the newest diabetes and obesity research in the fields of

epidemiology, biology, pathology, relationship between the two epidemics, diabetic complications,

prevention and clinical therapies. This lecture will benefit TCM practitioners by providing an overview of

cutting-edge diabetes research and therapeutic advancement, increasing health literacy, facilitating an

effective doctor-patient communication, and promote the effectiveness of the integration of TCM into

patients’ mainstream healthcare activities.

讲座题目:面对新世纪流行病肥胖和2型糖尿病,你和你的病人能从容应战吗?

简介:

朱智彤博士现就职于加拿大温哥华圣保罗医院。她拥有丰富的临床试验、卫生科研数据管

理、临床前研究和临床工作经验。朱博士在天津医科大学获得临床医学学士、药理学硕士

和病原生物学博士。她还在加拿大University of British Columbia获得临床流行病学硕士

学位。她自1994年开始从事内科临床工作,先后参与了多个药物临床试验、上市后产品

监测和临床前药物开发研究项目。近年来,她侧重于大规模人群的临床科研设计、数据分

析及临床试验性数据的收集、分析和管理。

 

讲座简介:

进入二十一世纪以来,肥胖和2型糖尿病席卷全球并对各国的公共卫生体系构成严峻的挑

战。2型糖尿病更从当年的富贵病演变为穷人也很流行的病, 从成人病演变为儿童易患的

疾病。世界范围内有2亿8千5百万糖尿病病人,其中 2百万是加拿大人。超重和肥胖是糖

尿病发病的高危因素,而有四分之一的15岁及以上的加拿大人属于超重。在这个肥胖和2

型糖尿病烽烟四起的年代,你是否准备好如何帮助你的病人应对挑战了?

 

凭借多年的西医临床实践和科研经验,朱博士将帮您解读这两个新世纪流行病的流行和发

病、两者之间的关联、糖尿病并发症,及防范和治疗。此讲座将为TCM医生提供西医药

机理和治疗的最新动态、帮助医患之间医学信息的有效沟通,以助临床实践中结合病人的

西医治疗方案而给出更针对性的建议。